3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition

Now that the FED is looking to lower interest rates this year, cheaper money and more accessible financing will let investors venture into riskier places in the economy and the stock market. While not that risky of an industry, the biotech space can often be speculative. This is because biotech stocks tend to move according to their trials and approvals for new technologies or drugs.Today, you are about to see how the markets have left enough evidence to figure out which of these will rise. It may be due to ...